Posted by Michael Wonder on 08 Jul 2019
Report calls for European funding reform for gene therapies
8 July 2019 - New payment models, dedicated investment, and better health technology assessment are among a raft of changes needed to bring regenerative medicines to patients in Europe, according to a new report.
The Alliance for Regenerative Medicine, an international advocacy organisation representing the cell and gene therapy and broader advanced therapies sector, published a consensus report containing recommendations to ensure European patients have access.
While regulators have systems in place to ensure rapid approval of Advanced Therapy Medicinal Products, payers and health technology assessment bodies do not always have mechanisms to capture the full benefits of these novel products.
